Tiffany joined the BHL in May 2021 as a Master’s student in Pharmaceutical Sciences to work on the role of NOX2 as a new drug target in Alzheimer’s disease to repair blood-brain barrier dysfunction. Tiffany successfully defended and will graduate with a dual PharmD/MS degree on May 3. Congratulations, Tiffany!

Suelen joins BHL
Suelen Santos Alves has joined BHL as a Postdoctoral Scholar. Originally from Brazil, Suelen will contribute to the lab’s research on blood-brain barrier dysfunction in Alzheimer’s disease with epilepsy. Welcome to the BHL, Suelen!

